Detection of tumour necrosis factor‐alpha in dogs with lymphoma*
- 21 April 2011
- journal article
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 9 (4) , 290-295
Abstract
Tumour necrosis factor-alpha (TNF-α) production by malignant lymphoblasts has been identified in vitro and in vivo in mice and humans, respectively. The goals of this study were (1) to evaluate a novel single-sample TNF-α assay and (2) to determine whether TNF-α is increased in dogs with lymphoma prior to and following treatment. Canine TNF-α was analysed concurrently using the novel Siemens Immulite® single-sample automated ELISA and the previously validated Quantikine® standard ELISA. Serum from dogs with lymphoma and from breed-, age- and gender-matched control dogs was evaluated at two time points. Three of 25 (12%) dogs with lymphoma had detectable TNF-α at diagnosis, whereas none had detectable TNF-α following complete or partial remission. TNF-α was not detectable in control dogs. Despite 91% homology between human and canine TNF-α, the Immulite® automated ELISA failed to detect canine TNF-α. Serum TNF-α appears to have limited value as a tumour marker in dogs with lymphoma.Keywords
This publication has 21 references indexed in Scilit:
- Effects of dietary supplementation with fish oil on in vivo production of inflammatory mediators in clinically normal dogsAmerican Journal of Veterinary Research, 2008
- Effects of subanesthetic doses of ketamine on hemodynamic and immunologic variables in dogs with experimentally induced endotoxemiaAmerican Journal of Veterinary Research, 2008
- Comparison of the Human and Canine Cytokines IL-1(α/β) and TNF-α to Orthologous Other MammaliansJournal of Heredity, 2007
- Veterinary co‐operative oncology group – common terminology criteria for adverse events (VCOG‐CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0Veterinary and Comparative Oncology, 2004
- Chemotherapy Followed by Half-Body Radiation Therapy for Canine LymphomaJournal of Veterinary Internal Medicine, 2004
- TheRole ofSuppressors ofCytokineSignaling(SOCS) Proteins inRegulation of theImmuneResponseAnnual Review of Immunology, 2004
- Kinetics of endotoxin concentration and tumor necrosis factor-α, interleukin-1β, and interleukin-6 activities in the systemic and portal circulation during small intestinal ischemia and reperfusion in dogsAmerican Journal of Veterinary Research, 2002
- ELEVATED CIRCULATING LEVELS OF TNFα AND ITS p55 SOLUBLE RECEPTOR ARE ASSOCIATED WITH AN ADVERSE PROGNOSIS IN LYMPHOMA PATIENTSBritish Journal of Haematology, 1996
- Evaluation of Prognostic Factors and Sequential Combination Chemotherapy With Doxorubicin for Canine LymphomaJournal of Veterinary Internal Medicine, 1993
- Prognostic Factors in Dogs with Lymphoma and Associated HypercalcemiaJournal of Veterinary Internal Medicine, 1991